73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Medicare to cover CAR-T therapy for leukemia, lymphoma

Medicare to cover CAR-T therapy for leukemia, lymphoma

A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.Chimeric antigen receptor T-cell (CAR-T)therapyboosts a patient's own immune cells

Medicare to cover CAR-T therapy for leukemia, lymphoma

A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.Chimeric antigen receptor T-cell (CAR-T)therapyboosts a patient's own immune cells
Using algorithms to track down cancer

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p
The search to discover why 'outliers' survive deadliest cancers

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of
Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit
Enhanced anticancer compound may allow precise activation and tracking of treatment

Enhanced anticancer compound may allow precise activation and tracking of treatment

by The Wistar InstituteCredit: The Wistar InstituteResearchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic

Enhanced anticancer compound may allow precise activation and tracking of treatment

by The Wistar InstituteCredit: The Wistar InstituteResearchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic
A code for reprogramming immune sentinels

A code for reprogramming immune sentinels

by Lund UniversityArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Credit: National Institutes of Health (NI

A code for reprogramming immune sentinels

by Lund UniversityArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Credit: National Institutes of Health (NI
Atezolizumab + bevacizumab shows benefit in met renal CA

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen
New cancer drug candidate targets immune system 'brakes'

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix
Study uncovers how B cells react to skin cancer

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ
Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur
Previous cancer treatment not tied to higher stillbirth rate

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs
Pathway tied to cancer-driving genome alterations identified

Pathway tied to cancer-driving genome alterations identified

byUTSouthwestern Medical CenterThese images show examples of mitotic chromosome spreads from human cancer cells containing a shattered chromosome (left panel) or extrachromosomal DNA (midd

Pathway tied to cancer-driving genome alterations identified

byUTSouthwestern Medical CenterThese images show examples of mitotic chromosome spreads from human cancer cells containing a shattered chromosome (left panel) or extrachromosomal DNA (midd